A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Acute Graft Vs Host Disease (aGVHD) in Patients Receiving Hematopoietic Cell Transplant (HCT)
Transplantation and Cellular Therapy（2021）
Key words
Graft-versus-Host Disease,Hematopoietic Cell Transplantation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined